| Gene symbol |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
| Adcy5 |  |
NM_001012765 |
adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] |
KLA | 1.06 |
1.00 |
.97 |
1.01 |
1.03 |
.95 |
.93 |
| ATP | .95 |
1.08 |
1.08 |
1.07 |
.97 |
1.03 |
.97 |
| KLA/ATP | .97 |
.92 |
1.04 |
.99 |
.91 |
.96 |
1.04 |
|
| Atf2 |  |
AK047405 |
10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930056P03 product:activating transcription factor 2, full insert sequence. [AK047405] |
KLA | 1.01 |
1.00 |
1.02 |
1.04 |
1.03 |
1.03 |
1.00 |
| ATP | .99 |
1.00 |
.95 |
1.01 |
1.04 |
.98 |
1.03 |
| KLA/ATP | 1.07 |
1.00 |
.98 |
.99 |
1.00 |
1.03 |
.93 |
|
| Atf2 | |
NM_001025093 |
activating transcription factor 2 (Atf2), transcript variant 1, mRNA [NM_001025093] |
KLA | 1.35 |
1.30 |
1.32 |
1.31 |
1.37 |
1.09 |
1.20 |
| ATP | 1.15 |
1.17 |
.99 |
1.11 |
1.22 |
1.39 |
1.28 |
| KLA/ATP | 1.38 |
1.42 |
1.21 |
1.28 |
1.17 |
1.33 |
1.69 |
|
| Atf4 |  |
NM_009716 |
activating transcription factor 4 (Atf4), mRNA [NM_009716] |
KLA | .91 |
1.06 |
1.13 |
1.31 |
1.92 |
2.59 |
3.01 |
| ATP | 1.05 |
1.14 |
1.34 |
2.88 |
4.84 |
2.36 |
2.56 |
| KLA/ATP | 1.14 |
1.08 |
1.17 |
2.40 |
3.72 |
3.54 |
3.62 |
|
| Bdnf |  |
NM_007540 |
brain derived neurotrophic factor (Bdnf), transcript variant 1, mRNA [NM_007540] |
KLA | 1.00 |
1.01 |
1.01 |
1.01 |
1.01 |
1.00 |
.99 |
| ATP | 1.00 |
1.00 |
1.00 |
1.01 |
.99 |
.99 |
1.01 |
| KLA/ATP | 1.00 |
1.01 |
1.01 |
1.02 |
1.03 |
1.03 |
.98 |
|
| Cdk5 |  |
NM_007668 |
cyclin-dependent kinase 5 (Cdk5), mRNA [NM_007668] |
KLA | .98 |
.98 |
.94 |
1.01 |
.98 |
.94 |
1.16 |
| ATP | 1.19 |
1.35 |
.97 |
1.37 |
.88 |
.57 |
1.26 |
| KLA/ATP | 1.02 |
1.10 |
.80 |
1.31 |
.74 |
.54 |
1.43 |
|
| Cdk5r1 |  |
NM_009871 |
cyclin-dependent kinase 5, regulatory subunit (p35) 1 (Cdk5r1), mRNA [NM_009871] |
KLA | .75 |
.66 |
.64 |
.72 |
.83 |
.68 |
.47 |
| ATP | .89 |
.79 |
1.31 |
2.63 |
5.19 |
2.49 |
.47 |
| KLA/ATP | .76 |
.79 |
1.28 |
2.78 |
4.40 |
2.47 |
1.24 |
|
| Creb1 |  |
NM_009952 |
cAMP responsive element binding protein 1 (Creb1), transcript variant B, mRNA [NM_009952] |
KLA | 1.42 |
1.33 |
1.16 |
.99 |
.83 |
.97 |
.92 |
| ATP | .92 |
.91 |
1.18 |
1.38 |
1.51 |
1.02 |
.75 |
| KLA/ATP | 1.34 |
1.31 |
1.49 |
1.37 |
1.71 |
1.05 |
.93 |
|
| Creb3 |  |
NM_013497 |
cAMP responsive element binding protein 3 (Creb3), mRNA [NM_013497] |
KLA | 1.21 |
1.21 |
1.23 |
1.53 |
1.77 |
1.77 |
1.31 |
| ATP | 1.02 |
1.03 |
.99 |
1.05 |
.82 |
.83 |
1.48 |
| KLA/ATP | 1.15 |
1.18 |
1.20 |
1.26 |
1.13 |
1.15 |
1.86 |
|
| Creb3l1 |  |
NM_011957 |
cAMP responsive element binding protein 3-like 1 (Creb3l1), mRNA [NM_011957] |
KLA | 1.18 |
1.17 |
1.53 |
1.28 |
1.22 |
1.11 |
1.23 |
| ATP | 1.01 |
1.09 |
.98 |
1.17 |
1.22 |
1.01 |
1.15 |
| KLA/ATP | 1.22 |
1.29 |
1.08 |
1.34 |
1.14 |
1.36 |
1.12 |
|
| Creb3l2 |  |
AK082964 |
12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530025K05 product:unclassifiable, full insert sequence [AK082964] |
KLA | .44 |
.38 |
.37 |
.40 |
.45 |
.42 |
.47 |
| ATP | .90 |
.78 |
1.22 |
.79 |
.54 |
.46 |
.44 |
| KLA/ATP | .41 |
.41 |
.49 |
.43 |
.50 |
.51 |
.23 |
|
| Creb3l2 | |
NM_178661 |
cAMP responsive element binding protein 3-like 2 (Creb3l2), mRNA [NM_178661] |
KLA | .98 |
.87 |
.76 |
.98 |
1.03 |
.87 |
1.12 |
| ATP | 1.20 |
1.18 |
1.50 |
1.35 |
.86 |
1.32 |
1.50 |
| KLA/ATP | .98 |
1.04 |
1.15 |
1.05 |
.79 |
1.27 |
1.25 |
|
| Creb3l3 |  |
NM_145365 |
cAMP responsive element binding protein 3-like 3 (Creb3l3), mRNA [NM_145365] |
KLA | .66 |
.75 |
.65 |
.85 |
1.04 |
1.44 |
1.73 |
| ATP | 1.02 |
.98 |
.97 |
1.09 |
.85 |
.69 |
1.11 |
| KLA/ATP | .70 |
.66 |
.71 |
.83 |
.80 |
.85 |
1.05 |
|
| Creb3l4 |  |
NM_030080 |
cAMP responsive element binding protein 3-like 4 (Creb3l4), mRNA [NM_030080] |
KLA | 1.55 |
1.42 |
1.51 |
1.73 |
1.76 |
2.54 |
1.38 |
| ATP | 1.07 |
.81 |
.89 |
1.08 |
.94 |
1.08 |
1.08 |
| KLA/ATP | 1.44 |
1.38 |
1.44 |
1.25 |
1.30 |
1.26 |
2.24 |
|
| Creb5 |  |
AK051306 |
12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130032G03 product:unclassifiable, full insert sequence. [AK051306] |
KLA | 2.18 |
2.13 |
2.42 |
1.97 |
1.57 |
1.94 |
1.98 |
| ATP | 1.11 |
1.09 |
1.47 |
1.74 |
1.36 |
1.44 |
1.62 |
| KLA/ATP | 2.55 |
2.77 |
3.02 |
3.15 |
2.51 |
2.52 |
2.61 |
|
| Creb5 | |
NM_172728 |
cAMP responsive element binding protein 5 (Creb5), mRNA [NM_172728] |
KLA | 3.70 |
3.60 |
2.84 |
2.39 |
1.92 |
2.81 |
1.84 |
| ATP | .92 |
.89 |
1.19 |
1.93 |
1.51 |
1.55 |
1.44 |
| KLA/ATP | 3.16 |
3.51 |
4.33 |
5.35 |
5.78 |
3.23 |
3.03 |
|
| Crebl1 |  |
NM_017406 |
cAMP responsive element binding protein-like 1 (Crebl1), mRNA [NM_017406] |
KLA | 1.22 |
1.30 |
1.32 |
1.34 |
1.51 |
1.52 |
1.75 |
| ATP | 1.13 |
1.32 |
1.16 |
1.66 |
1.06 |
.93 |
1.54 |
| KLA/ATP | 1.37 |
1.25 |
1.21 |
1.74 |
1.04 |
1.01 |
2.07 |
|
| Ddc |  |
NM_016672 |
dopa decarboxylase (Ddc), mRNA [NM_016672] |
KLA | 1.27 |
1.28 |
1.34 |
1.33 |
1.34 |
1.21 |
1.05 |
| ATP | 1.02 |
.99 |
1.05 |
.98 |
1.02 |
1.02 |
1.14 |
| KLA/ATP | 1.24 |
1.22 |
1.28 |
1.25 |
1.12 |
1.20 |
1.35 |
|
| Dlg4 |  |
NM_007864 |
discs, large homolog 4 (Drosophila) (Dlg4), transcript variant 1, mRNA [NM_007864] |
KLA | .97 |
.97 |
.95 |
.93 |
.99 |
1.01 |
1.03 |
| ATP | .98 |
1.00 |
.95 |
.96 |
.93 |
.98 |
1.01 |
| KLA/ATP | .96 |
.97 |
.95 |
.93 |
.91 |
1.00 |
.93 |
|
| Drd1a |  |
NM_010076 |
dopamine receptor D1A (Drd1a), mRNA [NM_010076] |
KLA | .94 |
.99 |
1.02 |
.98 |
.98 |
.99 |
1.06 |
| ATP | 1.07 |
1.03 |
1.01 |
1.08 |
1.08 |
.96 |
1.04 |
| KLA/ATP | 1.04 |
1.00 |
1.01 |
1.06 |
1.08 |
1.06 |
1.09 |
|
| Drd2 |  |
NM_010077 |
dopamine receptor 2 (Drd2), mRNA [NM_010077] |
KLA | 1.02 |
.98 |
1.03 |
1.09 |
1.07 |
.97 |
1.09 |
| ATP | 1.07 |
1.00 |
.98 |
1.11 |
1.03 |
1.01 |
1.03 |
| KLA/ATP | 1.13 |
1.12 |
1.09 |
1.08 |
1.02 |
1.01 |
1.11 |
|
| Drd2 | |
X55674 |
gb|M.musculus mRNA for D2A dopamine receptor [X55674] |
KLA | .95 |
1.00 |
1.06 |
.98 |
.97 |
1.02 |
1.02 |
| ATP | .97 |
.97 |
.99 |
.97 |
.99 |
.97 |
1.01 |
| KLA/ATP | .97 |
1.03 |
.91 |
.90 |
.95 |
.89 |
1.00 |
|
| Fosb |  |
NM_008036 |
FBJ osteosarcoma oncogene B (Fosb), mRNA [NM_008036] |
KLA | .99 |
.88 |
.61 |
1.01 |
.74 |
1.03 |
1.00 |
| ATP | 8.75 |
11.87 |
14.21 |
15.92 |
11.71 |
3.22 |
1.29 |
| KLA/ATP | 3.13 |
5.07 |
3.50 |
7.61 |
4.95 |
3.70 |
1.87 |
|
| Gnai1 |  |
NM_010305 |
guanine nucleotide binding protein (G protein), alpha inhibiting 1 (Gnai1), mRNA [NM_010305] |
KLA | .95 |
1.01 |
1.01 |
1.00 |
1.09 |
1.10 |
1.08 |
| ATP | 1.06 |
1.06 |
.99 |
1.15 |
1.02 |
.94 |
.99 |
| KLA/ATP | 1.02 |
1.04 |
.99 |
1.16 |
1.01 |
1.02 |
1.13 |
|
| Gnai2 |  |
NM_008138 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 (Gnai2), mRNA [NM_008138] |
KLA | .74 |
.79 |
.82 |
.74 |
.91 |
.97 |
1.10 |
| ATP | 1.07 |
1.16 |
.78 |
1.12 |
.78 |
.48 |
.82 |
| KLA/ATP | .91 |
.81 |
.53 |
.80 |
.60 |
.68 |
.87 |
|
| Gnai3 |  |
NM_010306 |
guanine nucleotide binding protein (G protein), alpha inhibiting 3 (Gnai3), mRNA [NM_010306] |
KLA | 1.23 |
1.24 |
1.14 |
1.06 |
.99 |
1.15 |
1.09 |
| ATP | .96 |
.93 |
.86 |
.64 |
1.34 |
2.02 |
1.35 |
| KLA/ATP | 1.20 |
1.24 |
.97 |
.76 |
1.21 |
1.62 |
1.17 |
|
| Gnas |  |
AF107847 |
neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] |
KLA | 1.04 |
.94 |
1.00 |
1.05 |
1.04 |
.98 |
1.00 |
| ATP | .98 |
.97 |
.96 |
1.00 |
.99 |
.98 |
1.02 |
| KLA/ATP | 1.04 |
1.02 |
.96 |
.95 |
1.01 |
.96 |
1.01 |
|
| Gnas | |
AK017423 |
10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] |
KLA | .85 |
1.08 |
.97 |
.92 |
1.05 |
1.03 |
1.08 |
| ATP | .99 |
1.30 |
2.11 |
1.73 |
1.23 |
1.01 |
1.02 |
| KLA/ATP | .96 |
1.06 |
1.58 |
1.34 |
1.29 |
1.05 |
.91 |
|
| Gnas | |
NM_001077510 |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] |
KLA | .99 |
1.03 |
.97 |
.91 |
1.03 |
.95 |
.97 |
| ATP | 1.04 |
1.19 |
1.15 |
1.61 |
1.24 |
.91 |
1.00 |
| KLA/ATP | 1.06 |
.97 |
1.01 |
1.46 |
1.04 |
.85 |
1.01 |
|
| Gnas | |
S49980 |
gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] |
KLA | .91 |
.88 |
1.03 |
.87 |
.90 |
.84 |
1.01 |
| ATP | 1.16 |
1.22 |
1.02 |
1.55 |
1.16 |
.80 |
.99 |
| KLA/ATP | 1.01 |
1.13 |
.86 |
1.12 |
.97 |
.85 |
1.08 |
|
| Gpsm1 |  |
NM_153410 |
G-protein signalling modulator 1 (AGS3-like, C. elegans) (Gpsm1), mRNA [NM_153410] |
KLA | .61 |
.59 |
.55 |
.63 |
.59 |
.46 |
.52 |
| ATP | .92 |
.87 |
1.23 |
.93 |
.87 |
1.07 |
.54 |
| KLA/ATP | .56 |
.57 |
.72 |
.58 |
.85 |
.76 |
.36 |
|
| Gria2 |  |
BC048248 |
glutamate receptor, ionotropic, AMPA2 (alpha 2), mRNA (cDNA clone MGC:54603 IMAGE:6494013), complete cds. [BC048248] |
KLA | 1.00 |
1.01 |
1.05 |
1.00 |
1.03 |
.97 |
1.06 |
| ATP | .98 |
1.00 |
1.00 |
.96 |
1.03 |
1.05 |
1.04 |
| KLA/ATP | .98 |
1.08 |
.99 |
1.04 |
1.06 |
1.02 |
1.05 |
|
| Gria2 | |
NM_013540 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) (Gria2), transcript variant 2, mRNA [NM_013540] |
KLA | 1.02 |
1.02 |
.98 |
1.01 |
.98 |
1.02 |
1.01 |
| ATP | .95 |
1.01 |
.95 |
.99 |
1.09 |
1.02 |
1.09 |
| KLA/ATP | 1.06 |
.92 |
.96 |
.99 |
1.00 |
1.03 |
1.00 |
|
| Grin1 |  |
NM_008169 |
glutamate receptor, ionotropic, NMDA1 (zeta 1) (Grin1), mRNA [NM_008169] |
KLA | .90 |
.97 |
.91 |
.98 |
.93 |
.94 |
1.01 |
| ATP | 1.04 |
1.04 |
1.02 |
1.08 |
.96 |
.91 |
.93 |
| KLA/ATP | .90 |
.99 |
.95 |
.95 |
.94 |
.88 |
.89 |
|
| Grin2a |  |
NM_008170 |
glutamate receptor, ionotropic, NMDA2A (epsilon 1) (Grin2a), mRNA [NM_008170] |
KLA | 1.00 |
1.08 |
1.00 |
1.03 |
1.09 |
1.02 |
1.04 |
| ATP | .96 |
.94 |
1.00 |
.98 |
1.03 |
.97 |
1.01 |
| KLA/ATP | .95 |
1.02 |
1.03 |
.95 |
.99 |
.99 |
.95 |
|
| Grin2b |  |
NM_008171 |
glutamate receptor, ionotropic, NMDA2B (epsilon 2) (Grin2b), mRNA [NM_008171] |
KLA | 1.03 |
1.02 |
1.10 |
1.09 |
1.02 |
1.03 |
1.08 |
| ATP | 1.15 |
1.07 |
1.05 |
1.07 |
1.08 |
1.04 |
1.02 |
| KLA/ATP | 1.10 |
1.04 |
1.07 |
1.13 |
1.09 |
1.08 |
1.06 |
|
| Grin2c |  |
NM_010350 |
glutamate receptor, ionotropic, NMDA2C (epsilon 3) (Grin2c), mRNA [NM_010350] |
KLA | 1.09 |
1.13 |
1.19 |
1.24 |
1.14 |
1.15 |
1.09 |
| ATP | 1.05 |
.96 |
.98 |
.98 |
.94 |
1.01 |
1.10 |
| KLA/ATP | 1.08 |
1.14 |
1.09 |
1.05 |
1.05 |
.98 |
1.01 |
|
| Grin2d |  |
NM_008172 |
glutamate receptor, ionotropic, NMDA2D (epsilon 4) (Grin2d), mRNA [NM_008172] |
KLA | 1.57 |
1.18 |
1.35 |
1.45 |
1.25 |
1.49 |
.91 |
| ATP | .92 |
.99 |
1.45 |
1.66 |
1.54 |
2.02 |
1.15 |
| KLA/ATP | 1.23 |
1.38 |
2.08 |
2.28 |
1.92 |
2.53 |
1.92 |
|
| Grin3a |  |
AK044171 |
10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830097C19 product:similar to IONOTROPIC GLUTAMATE RECEPTOR NMDA subunit NR3A[Rattus norvegicus], full insert sequence. [AK044171] |
KLA | 1.06 |
1.00 |
.93 |
.95 |
.97 |
.97 |
.99 |
| ATP | .96 |
.97 |
1.02 |
.94 |
1.03 |
1.02 |
1.03 |
| KLA/ATP | 1.05 |
.96 |
1.05 |
.98 |
.94 |
1.02 |
1.03 |
|
| Grin3b |  |
NM_130455 |
glutamate receptor, ionotropic, NMDA3B (Grin3b), mRNA [NM_130455] |
KLA | .90 |
.92 |
.88 |
.98 |
.91 |
.91 |
.69 |
| ATP | .96 |
.93 |
.94 |
.92 |
.93 |
.84 |
.68 |
| KLA/ATP | .92 |
.88 |
.88 |
.95 |
.96 |
.88 |
.68 |
|
| Grm2 |  |
AK015353 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4930441L02 product:unclassifiable, full insert sequence [AK015353] |
KLA | 1.01 |
1.07 |
1.07 |
1.07 |
.99 |
.97 |
.98 |
| ATP | 1.03 |
1.05 |
.96 |
1.04 |
1.02 |
.90 |
.94 |
| KLA/ATP | 1.05 |
1.08 |
1.02 |
.99 |
.94 |
.98 |
1.01 |
|
| Grm2 | |
XM_001475814 |
gb|PREDICTED: Mus musculus G protein-coupled receptor, family C, group 1, member B (Grm2), mRNA [XM_001475814] |
KLA | 1.01 |
1.02 |
.94 |
.98 |
1.01 |
.99 |
.99 |
| ATP | 1.03 |
1.01 |
1.03 |
1.03 |
1.05 |
1.01 |
1.03 |
| KLA/ATP | 1.02 |
.97 |
1.05 |
1.00 |
.98 |
1.02 |
1.08 |
|
| Grm3 |  |
NM_181850 |
glutamate receptor, metabotropic 3 (Grm3), mRNA [NM_181850] |
KLA | .95 |
1.00 |
1.00 |
1.01 |
.96 |
.99 |
.99 |
| ATP | .97 |
1.02 |
.99 |
1.08 |
1.05 |
1.02 |
1.04 |
| KLA/ATP | 1.00 |
.98 |
.99 |
1.07 |
1.07 |
1.03 |
1.04 |
|
| Jun |  |
NM_010591 |
Jun oncogene (Jun), mRNA [NM_010591] |
KLA | 1.08 |
.96 |
1.09 |
1.09 |
.75 |
.88 |
.81 |
| ATP | 1.26 |
1.48 |
4.45 |
8.73 |
4.02 |
1.16 |
1.99 |
| KLA/ATP | 1.12 |
1.38 |
3.52 |
5.17 |
3.32 |
.49 |
1.42 |
|
| Maoa |  |
NM_173740 |
monoamine oxidase A (Maoa), nuclear gene encoding mitochondrial protein, mRNA [NM_173740] |
KLA | 1.14 |
1.11 |
1.06 |
1.07 |
.84 |
.55 |
.53 |
| ATP | 1.10 |
1.07 |
1.33 |
1.20 |
1.44 |
2.37 |
1.38 |
| KLA/ATP | .97 |
1.11 |
1.75 |
1.33 |
1.27 |
1.21 |
1.09 |
|
| Maob |  |
NM_172778 |
monoamine oxidase B (Maob), nuclear gene encoding mitochondrial protein, mRNA [NM_172778] |
KLA | 1.01 |
.97 |
1.01 |
1.05 |
1.01 |
.95 |
1.01 |
| ATP | 1.09 |
.98 |
.99 |
.97 |
1.03 |
1.03 |
.94 |
| KLA/ATP | 1.02 |
1.05 |
.99 |
1.02 |
1.00 |
.98 |
.98 |
|
Mm.24833
5 |  |
110350004 |
Unknown |
KLA | .83 |
.79 |
.63 |
.93 |
.75 |
1.10 |
1.03 |
| ATP | 10.10 |
12.76 |
17.13 |
18.61 |
13.01 |
3.37 |
1.36 |
| KLA/ATP | 3.05 |
5.96 |
4.94 |
8.73 |
5.80 |
4.08 |
1.91 |
|
Mm.32259
4 |  |
144922605 |
Unknown |
KLA | 1.02 |
1.03 |
.98 |
.98 |
.95 |
1.00 |
1.02 |
| ATP | 1.01 |
.98 |
1.08 |
1.01 |
1.04 |
1.01 |
.97 |
| KLA/ATP | .97 |
1.08 |
1.04 |
1.02 |
1.00 |
1.01 |
1.03 |
|
Mm.41137
|  |
148747308 |
Unknown |
KLA | 1.03 |
1.00 |
.95 |
.92 |
1.04 |
.98 |
.96 |
| ATP | 1.02 |
.98 |
.98 |
.90 |
.95 |
.92 |
1.07 |
| KLA/ATP | .91 |
.89 |
1.01 |
.95 |
1.00 |
.96 |
.99 |
|
Mm.44009
5 |  |
166158133 |
Unknown |
KLA | .99 |
1.03 |
1.07 |
1.00 |
1.07 |
1.07 |
1.06 |
| ATP | .98 |
1.01 |
.98 |
.94 |
1.06 |
.96 |
.95 |
| KLA/ATP | 1.04 |
1.05 |
1.00 |
.97 |
1.06 |
.99 |
.95 |
|
Mm.47428
2 |  |
40254597 |
Unknown |
KLA | .93 |
.82 |
.93 |
.87 |
.88 |
.77 |
.53 |
| ATP | .98 |
.93 |
1.73 |
2.36 |
4.80 |
3.05 |
.50 |
| KLA/ATP | .99 |
1.00 |
1.68 |
2.58 |
3.88 |
2.65 |
1.22 |
|
Mm.54161
|  |
164607143 |
Unknown |
KLA | .97 |
.99 |
1.00 |
.98 |
.95 |
.98 |
.94 |
| ATP | 1.01 |
.99 |
1.06 |
1.07 |
1.02 |
.95 |
.98 |
| KLA/ATP | .93 |
1.04 |
1.07 |
.96 |
.90 |
.95 |
.94 |
|
| Nfkb1 |  |
BC050841 |
nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] |
KLA | 5.81 |
4.96 |
4.77 |
3.21 |
3.37 |
2.00 |
1.71 |
| ATP | 1.39 |
1.52 |
3.25 |
12.63 |
13.64 |
4.80 |
1.08 |
| KLA/ATP | 7.21 |
8.69 |
19.53 |
23.93 |
11.70 |
2.85 |
2.01 |
|
| Nfkb1 | |
M57999 |
gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] |
KLA | 8.55 |
7.87 |
7.35 |
6.13 |
3.51 |
1.85 |
1.38 |
| ATP | .98 |
.96 |
1.21 |
3.06 |
5.29 |
4.67 |
.69 |
| KLA/ATP | 7.32 |
7.20 |
8.71 |
10.82 |
5.55 |
2.77 |
1.54 |
|
| Ppp1r1b |  |
NM_144828 |
protein phosphatase 1, regulatory (inhibitor) subunit 1B (Ppp1r1b), mRNA [NM_144828] |
KLA | 1.20 |
1.17 |
1.12 |
1.24 |
1.22 |
1.18 |
1.06 |
| ATP | .97 |
1.09 |
1.06 |
1.13 |
1.04 |
1.17 |
1.12 |
| KLA/ATP | 1.09 |
1.10 |
1.27 |
1.28 |
1.10 |
1.12 |
1.12 |
|
| Prkaca |  |
NM_008854 |
protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] |
KLA | .71 |
.74 |
.72 |
.70 |
.72 |
.84 |
.85 |
| ATP | 1.05 |
.98 |
.89 |
.92 |
.76 |
.60 |
1.02 |
| KLA/ATP | .79 |
.74 |
.55 |
.65 |
.60 |
.65 |
.93 |
|
| Prkacb |  |
NM_011100 |
protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] |
KLA | .69 |
.70 |
.66 |
.58 |
.51 |
.55 |
.59 |
| ATP | 1.02 |
1.19 |
.97 |
1.01 |
.69 |
.38 |
.56 |
| KLA/ATP | .72 |
.73 |
.57 |
.62 |
.47 |
.41 |
.45 |
|
| Prkx |  |
NM_016979 |
protein kinase, X-linked (Prkx), mRNA [NM_016979] |
KLA | 3.61 |
3.79 |
4.67 |
4.66 |
4.85 |
4.19 |
1.43 |
| ATP | .98 |
.90 |
.63 |
.61 |
1.12 |
1.90 |
1.29 |
| KLA/ATP | 3.56 |
3.36 |
2.62 |
2.06 |
2.26 |
2.87 |
2.31 |
|
| Rela |  |
NM_009045 |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] |
KLA | 2.05 |
2.05 |
2.07 |
1.75 |
1.83 |
1.58 |
1.33 |
| ATP | 1.03 |
1.08 |
1.10 |
1.44 |
1.61 |
2.48 |
1.05 |
| KLA/ATP | 2.17 |
2.27 |
2.05 |
2.47 |
1.93 |
2.35 |
2.02 |
|
| Rgs9 |  |
NM_011268 |
regulator of G-protein signaling 9 (Rgs9), mRNA [NM_011268] |
KLA | 1.06 |
.99 |
1.02 |
1.01 |
1.02 |
1.06 |
1.03 |
| ATP | 1.03 |
.95 |
1.06 |
1.09 |
1.15 |
1.24 |
1.00 |
| KLA/ATP | 1.07 |
1.02 |
1.05 |
1.08 |
1.17 |
1.28 |
1.41 |
|
| Slc18a1 |  |
AK049514 |
7 days embryo whole body cDNA, RIKEN full-length enriched library, clone:C430018J19 product:CHROMAFFIN GRANULE AMINE TRANSPORTER (VESICULAR AMINE TRANSPORTER 1) (VAT1) homolog [Rattus norvegicus], full insert sequence. [AK049514] |
KLA | 1.08 |
1.09 |
1.04 |
1.02 |
1.06 |
1.01 |
.99 |
| ATP | .98 |
.94 |
.98 |
.98 |
1.08 |
.98 |
1.03 |
| KLA/ATP | 1.01 |
.97 |
.94 |
1.06 |
1.03 |
1.01 |
1.24 |
|
| Slc18a1 | |
NM_153054 |
solute carrier family 18 (vesicular monoamine), member 1 (Slc18a1), mRNA [NM_153054] |
KLA | 1.13 |
1.10 |
1.33 |
1.27 |
1.37 |
1.41 |
1.56 |
| ATP | .86 |
.78 |
.83 |
.61 |
.70 |
.45 |
1.22 |
| KLA/ATP | .96 |
1.02 |
.92 |
.73 |
.94 |
.90 |
4.36 |
|
| Slc18a2 |  |
NM_172523 |
solute carrier family 18 (vesicular monoamine), member 2 (Slc18a2), mRNA [NM_172523] |
KLA | .98 |
.97 |
.95 |
.94 |
.94 |
.99 |
.92 |
| ATP | .98 |
1.01 |
.96 |
.95 |
.96 |
.96 |
.98 |
| KLA/ATP | .91 |
.94 |
.91 |
.92 |
.96 |
.95 |
.93 |
|
| Slc6a3 |  |
NM_010020 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 (Slc6a3), mRNA [NM_010020] |
KLA | 1.03 |
.97 |
1.04 |
1.02 |
1.02 |
1.01 |
.98 |
| ATP | 1.02 |
.98 |
.91 |
1.00 |
.98 |
1.00 |
.98 |
| KLA/ATP | .97 |
.90 |
1.02 |
1.03 |
1.01 |
.90 |
.99 |
|
| Th |  |
NM_009377 |
tyrosine hydroxylase (Th), mRNA [NM_009377] |
KLA | 1.00 |
1.01 |
1.00 |
1.00 |
1.00 |
1.00 |
1.00 |
| ATP | .98 |
1.01 |
1.00 |
1.00 |
1.00 |
.99 |
1.01 |
| KLA/ATP | 1.00 |
1.01 |
1.01 |
1.00 |
1.01 |
.98 |
1.02 |
|
: View data/graphs for replicates
ATP
ATP+KLA